ELC
MDT icon

Edgar Lomax Company’s Medtronic MDT Stock Holding History

Edgar Lomax Company’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.9M Sell
171,745
-83,355
-33% -$7.99M 1.06% 41
2025
Q4 		$24.5M Sell
255,100
-5,830
-2% -$566K 1.86% 19
2025
Q3 		$24.9M Sell
260,930
-76,155
-23% -$7M 1.95% 19
2025
Q2 		$29.4M Sell
337,085
-5,400
-2% -$458K 1.86% 20
2025
Q1 		$30.8M Buy
342,485
+24,905
+8% +$2.23M 1.92% 20
2024
Q4 		$25.4M Sell
317,580
-6,080
-2% -$526K 1.64% 26
2024
Q3 		$29.1M Sell
323,660
-5,115
-2% -$430K 1.78% 23
2024
Q2 		$25.9M Sell
328,775
-5,835
-2% -$478K 1.68% 25
2024
Q1 		$29.2M Sell
334,610
-3,188
-0.9% -$272K 1.8% 22
2023
Q4 		$27.8M Sell
337,798
-13,700
-4% -$1.04M 1.82% 24
2023
Q3 		$27.5M Sell
351,498
-5,845
-2% -$489K 1.88% 25
2023
Q2 		$31.5M Sell
357,343
-4,832
-1% -$416K 2.07% 23
2023
Q1 		$29.2M Buy
362,175
+172,105
+91% +$14M 1.88% 24
2022
Q4 		$14.8M Sell
190,070
-1,880
-1% -$152K 0.9% 39
2022
Q3 		$15.5M Sell
191,950
-2,155
-1% -$194K 1.07% 36
2022
Q2 		$17.4M Buy
194,105
+5,255
+3% +$532K 1.09% 31
2022
Q1 		$21M Buy
+188,850
New +$20M 1.23% 31
2019
Q1 		– Sell
-175,275
Closed -$15.9M – 73
2018
Q4 		$15.9M Sell
175,275
-3,100
-2% -$290K 1.21% 26
2018
Q3 		$17.5M Sell
178,375
-6,200
-3% -$573K 1.18% 29
2018
Q2 		$15.8M Buy
184,575
+1,500
+0.8% +$125K 1.11% 30
2018
Q1 		$14.7M Buy
+183,075
New +$15.1M 1.06% 33
2015
Q1 		– Sell
-26,300
Closed -$1.9M – 66
2014
Q4 		$1.9M Sell
26,300
-606,159
-96% -$42.1M 0.12% 56
2014
Q3 		$39.2M Buy
632,459
+15,760
+3% +$1M 2.66% 17
2014
Q2 		$39.3M Buy
616,699
+1,075
+0.2% +$65.3K 2.78% 16
2014
Q1 		$37.9M Buy
615,624
+54,950
+10% +$3.2M 2.79% 15
2013
Q4 		$32.2M Buy
560,674
+272,700
+95% +$15.5M 2.43% 16
2013
Q3 		$15.3M Sell
287,974
-25,800
-8% -$1.39M 1.26% 35
2013
Q2 		$16.1M Buy
+313,774
New +$15.5M 1.26% 33

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Edgar Lomax Company's MDT Position: Q1 2026 in Review

Edgar Lomax Company reduced its Medtronic (MDT) stake by 33% in Q1 2026, selling an estimated $7.99M and leaving 171,745 shares worth $14.9M. The position accounts for 1.06% of the portfolio, ranked #41.

Edgar Lomax Company first reported a position in MDT in Q2 2013 and has held it in 28 quarters since. The position peaked at $39.3M in Q2 2014. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Edgar Lomax Company held 171,745 shares of Medtronic worth $14.9M as of Q1 2026.
  • Edgar Lomax Company sold 83,355 Medtronic shares in Q1 2026, an estimated $7.99M.
  • Medtronic made up 1.06% of Edgar Lomax Company's portfolio in Q1 2026, its #41 holding.
  • Edgar Lomax Company first reported a position in Medtronic in Q2 2013 and has held it in 28 quarters since.
  • Edgar Lomax Company's Medtronic position peaked at $39.3M in Q2 2014.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Edgar Lomax Company's 13F filing for Q1 2026, filed 12 May 2026.